Security key
501976104
Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (KYTX)
CUSIP: 501976104
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, par value $0.00001 per share
- Shares outstanding
- 56,833,213
- Total 13F shares
- 25,800,890
- Share change
- -3,088,568
- Total reported value
- $49,797,231
- Put/Call ratio
- 100%
- Price per share
- $1.93
- Number of holders
- 86
- Value change
- -$8,775,592
- Number of buys
- 39
- Number of sells
- 40
Report period
Q1 2025
Institutions
86
Top holders
10
KYTX full security history
Newer quarter: Q2 2025
Previous quarter: Q4 2024
Kyverna Therapeutics, Inc. SEC filings
Kyverna Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 501976104
Recent filing periods:
Top shareholders of KYTX - Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Vida Ventures Advisors, LLC |
13F
|
Company |
8%
|
4,523,924
|
$16,919,476 | — | 31 Dec 2024 | |
| GILEAD SCIENCES, INC. |
13F
3/4/5
|
Company · 10%+ Owner |
7.3%
|
4,126,119
|
$15,431,685 | — | 31 Dec 2024 | |
| Bain Capital Life Sciences Investors, LLC |
13F
3/4/5
|
Company · 10%+ Owner |
5.9%
|
3,368,370
|
$12,597,704 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
3.8%
|
2,166,437
|
$8,102,474 | — | 31 Dec 2024 | |
| Novo Holdings A/S |
13F
|
Company |
3.3%
|
1,850,000
|
$6,919,000 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
2.9%
|
1,672,493
|
$6,255,123 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.3%
|
1,313,232
|
$4,911,489 | — | 31 Dec 2024 | |
| Insight Holdings Group, LLC |
13F
|
Company |
1.6%
|
912,915
|
$3,414,302 | — | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.3%
|
746,521
|
$2,791,989 | — | 31 Dec 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.2%
|
692,028
|
$2,588,185 | — | 31 Dec 2024 | |
| MBB PUBLIC MARKETS I LLC |
13F
|
Company |
1.1%
|
614,477
|
$2,298,144 | — | 31 Dec 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1%
|
593,688
|
$2,222,000 | — | 31 Dec 2024 | |
| Catalio Capital Management, LP |
13F
|
Company |
1%
|
586,909
|
$2,195,040 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.95%
|
539,682
|
$2,018,670 | — | 31 Dec 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.81%
|
461,959
|
$1,727,727 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.67%
|
379,888
|
$1,420,781 | — | 31 Dec 2024 | |
| Kera Capital Partners, Inc. |
13F
|
Company |
0.66%
|
376,131
|
$1,406,730 | — | 31 Dec 2024 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.62%
|
350,000
|
$1,309,000 | — | 31 Dec 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.48%
|
274,414
|
$1,026,308 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.36%
|
203,403
|
$760,727 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.35%
|
200,594
|
$750,222 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.34%
|
195,694
|
$731,896 | — | 31 Dec 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.33%
|
190,383
|
$712,032 | — | 31 Dec 2024 | |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
|
Company |
0.32%
|
182,177
|
$681,342 | — | 31 Dec 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.32%
|
181,654
|
$679,386 | — | 31 Dec 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.31%
|
179,012
|
$669,505 | — | 31 Dec 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.31%
|
178,963
|
$669,322 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.3%
|
169,780
|
$634,977 | — | 31 Dec 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.29%
|
162,319
|
$607,073 | — | 31 Dec 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.21%
|
118,758
|
$444,155 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.2%
|
113,474
|
$424,393 | — | 31 Dec 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.16%
|
90,242
|
$337,505 | — | 31 Dec 2024 | |
| Verition Fund Management LLC |
13F
|
Company |
0.16%
|
90,235
|
$337,479 | — | 31 Dec 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.16%
|
89,586
|
$335,052 | — | 31 Dec 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.14%
|
80,290
|
$300,285 | — | 31 Dec 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.14%
|
80,000
|
$299,200 | — | 31 Dec 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.09%
|
52,361
|
$195,830 | — | 31 Dec 2024 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.08%
|
45,000
|
$168,300 | — | 31 Dec 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.08%
|
44,983
|
$168,236 | — | 31 Dec 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.08%
|
44,700
|
$167,178 | — | 31 Dec 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.08%
|
43,949
|
$164,369 | — | 31 Dec 2024 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.08%
|
43,762
|
$163,670 | — | 31 Dec 2024 | |
| NORGES BANK |
13F
|
Company |
0.07%
|
40,000
|
$149,600 | — | 31 Dec 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.07%
|
39,933
|
$149,349 | — | 31 Dec 2024 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.07%
|
39,342
|
$147,140 | — | 31 Dec 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.07%
|
37,794
|
$141,350 | — | 31 Dec 2024 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.06%
|
34,912
|
$130,571 | — | 31 Dec 2024 | |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO |
13F
|
Company |
0.06%
|
33,434
|
$125,043 | — | 31 Dec 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.06%
|
32,000
|
$119,680 | — | 31 Dec 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.05%
|
30,010
|
$112,237 | — | 31 Dec 2024 |
Institutional Holders of Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (KYTX) as of Q1 2025
As of 31 Mar 2025,
Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (KYTX) was held by
86 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,800,890 shares.
The largest 10 holders included
Vida Ventures Advisors, LLC, GILEAD SCIENCES, INC., Bain Capital Life Sciences Investors, LLC, Novo Holdings A/S, BlackRock, Inc., VANGUARD GROUP INC, CITADEL ADVISORS LLC, Insight Holdings Group, LLC, FRANKLIN RESOURCES INC, and MBB PUBLIC MARKETS I LLC.
This page lists
86
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
87
Q1 2025 holders
86
Holder diff
-1
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.